Table 3. VAS meta-analysis results.
Study or subgroup | Experimental | Control | Weight | Std. Mean Difference | ||||
---|---|---|---|---|---|---|---|---|
Mean | SD | Total | Mean | SD | Total | IV, Random, 95% CI | ||
Gomiero et al., 2017 | 4.6 | 0.38 | 32 | 4.1 | 0.47 | 32 | 12.8% | 1.16 [0.62, 1.69] |
Hussein et al., 2015 | 40.0 | 14.23 | 38 | 42.8 | 15.21 | 21 | 12.8% | -0.19 [-0.72, 0.34] |
Cho et al., 2015 | 50.0 | 7.7 | 23 | 67.2 | 7.2 | 23 | 12.1% | -2.27 [-3.02, -1.51] |
Jahanjoo et al., 2019 | 3.43 | 0.23 | 30 | 3.83 | 0.21 | 30 | 12.6% | -1.79 [-2.40, -1.19] |
Kuru Colak et al., 2017 | 39.58 | 4.39 | 33 | 50.09 | 6.99 | 23 | 12.5% | -1.85 [-2.49, -1.21] |
Oh et al., 2020 | 4.2 | 1.7 | 13 | 4.9 | 1.4 | 13 | 12.0% | -0.44 [-1.21, 0.34] |
Reza et al., 2018 | 4.6 | 1.91 | 15 | 5.4 | 2.09 | 15 | 12.2% | -0.39 [-1.11, 0.33] |
Tunay et al., 2010 | 1.46 | 2.04 | 30 | 2.8 | 2.02 | 30 | 12.9% | -0.65 [-1.17, -0.13] |
Total (95% CI) | 214 | 187 | 100.0% | -0.79 [-1.59, 0.01] |
Heterogeneity: Tau 2 = 1.22; Chi 2 = 92.84, df = 7 (p < 0.00001); I 2 = 92%.
Test for overall effect: Z = 1.95 (p = 0.05).